{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:18:36Z","timestamp":1770927516074,"version":"3.50.1"},"reference-count":110,"publisher":"Informa UK Limited","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Drug Safety"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1517\/14740338.5.3.351","type":"journal-article","created":{"date-parts":[[2006,4,13]],"date-time":"2006-04-13T07:39:51Z","timestamp":1144913991000},"page":"351-360","source":"Crossref","is-referenced-by-count":8,"title":["Combination conjugate vaccines"],"prefix":"10.1517","volume":"5","author":[{"given":"Naor","family":"Bar-Zeev","sequence":"first","affiliation":[{"name":"Fellow in Infectious Diseases, Royal Children\u2019s Hospital, Infectious Diseases Unit, Department of General Medicine, Melbourne, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim P","family":"Buttery","sequence":"additional","affiliation":[{"name":"Fellow in Infectious Diseases, Royal Children\u2019s Hospital, Infectious Diseases Unit, Department of General Medicine, Melbourne, Australia"},{"name":"Research Development Director, NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Childrens Research Institute, University of Melbourne Department of Paediatrics, Royal Children's Hospital, Flemington Rd, Parkville, VIC 3052, Australia."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2006,4,13]]},"reference":[{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.14.1751"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/322560"},{"key":"e_1_3_1_5_1","unstructured":"FOOD AND DRUG ADMINISTRATION AND US DEPARTMENT OF HEALTH AND HUMAN SERVICES: Guidance for industry for the evaluation of combination vaccines for preventable diseases: production testing and clinical studies. Rockville Maryland USA (1997)."},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2005.072173"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/61.1.63"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1086\/322578"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1086\/322562"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/322563"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198710083171503"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198406143102404"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200009000-00009"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200210000-00011"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00389-X"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.6.1100"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/153.1.1"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-197303000-00001"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/149.6.1034"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00517-X"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)04377-9"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1086\/322561"},{"key":"e_1_3_1_23_1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1542\/peds.85.4.667","volume":"85","author":"WARD","year":"1990","unstructured":"WARD J: Commentary: results of efficacy trials in Alaska and Finland of Haemophilus influenzae type b conjugate vaccine. Pediatrics (1990) 85(4 Pt 2):667.","journal-title":"Pediatrics"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.017"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/314901"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1086\/314989"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199912000-00019"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1086\/516154"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1086\/517407"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106203242503"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.9.5383-5391.2004"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020015"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050544"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200012000-00003"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1995.tb44461.x"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00458-7"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(02)00151-2"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/338474"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1086\/378744"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)83529-2"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500020080036"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1086\/315018"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022823"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.16.2043"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.08.051"},{"key":"e_1_3_1_46_1","first-page":"893","volume":"54","author":"CENTERS","year":"2005","unstructured":"CENTERS FOR DISEASE CONTROL AND PREVENTION: Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb. Mortal. Wkly. Rep. (2005) 54(36):893-897.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7385.365"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16725-1"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.135.4.2319"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.5.2093-2098.1998"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1086\/324007"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.10.3504-3510.1991"},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00162-5"},{"key":"e_1_3_1_54_1","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4049\/jimmunol.142.8.2635","volume":"142","author":"SCHUTZE","year":"1989","unstructured":"SCHUTZE MP, DERIAUD E, PRZEWLOCKI G, LECLERC C: Carrier-induced epitopic suppression is initiated through clonal dominance. J. Immunol. (1989) 142(8):2635-2640.","journal-title":"J. Immunol."},{"key":"e_1_3_1_55_1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.145.5.1343","volume":"145","author":"LECLERC","year":"1990","unstructured":"LECLERC C, SCHUTZE MP, DERIAUD E, PRZEWLOCKI G: The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. J. Immunol. (1990) 145(5):1343-1349.","journal-title":"J. Immunol."},{"key":"e_1_3_1_56_1","volume-title":"The Australian Immunisation Handbook","year":"2003","unstructured":"COMMONWEALTH OF AUSTRALIA: The Australian Immunisation Handbook, 8th Edition (2003)."},{"key":"e_1_3_1_57_1","first-page":"427","volume":"39","author":"CHERIAN","year":"2002","unstructured":"CHERIAN T, THOMAS N, RAGHUPATHY P, DUROT I, DUTTA A: Safety and immunogenicity of Haemophilus influenzae type B vaccine given in combination with DTwP at 6, 10 and 14 weeks of age. Indian Pediatr. (2002) 39(5):427-436.","journal-title":"Indian Pediatr."},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199312000-00003"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(94)70328-0"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1185\/0300799039117063"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)04356-5"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199709000-00009"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1086\/315511"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050797"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1086\/514741"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)84511-2"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199804000-00006"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199110000-00009"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2000.107796"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199712000-00004"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00241-7"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00114-5"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02725508"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(95)00260-8"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.1.25"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00149-9"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410017572"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1086\/426396"},{"key":"e_1_3_1_79_1","volume-title":"Proceedings of the 39th ICAAC","author":"SCHMITT","year":"1999","unstructured":"SCHMITT HJ, SEIDLER A, NEISSING W, WEIL J: DTPa Hib combination vaccines: population-based estimation of effectiveness by capture-recapture technique. Proceedings of the 39th ICAAC, San Francisco, California, USA (1999)."},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12441-5"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200108000-00010"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12385-9"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1086\/376997"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1086\/314569"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00549-6"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00047-X"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200005000-00006"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199706000-00010"},{"key":"e_1_3_1_89_1","first-page":"285","volume":"57","author":"PETERSEN","year":"1998","unstructured":"PETERSEN K, BULKOW L, MCMAHON B, WAINWRIGHT R, PETERS H: Immunogenicity of a combined hepatitis B and Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. Int. J. Circumpolar. Health (1998) 57(Suppl. 1):285-292.","journal-title":"Int. J. Circumpolar. Health"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.1992.tb02691.x"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200115060-00007"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200003000-00003"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-199909000-00004"},{"key":"e_1_3_1_94_1","doi-asserted-by":"publisher","DOI":"10.1086\/315009"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1086\/514063"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.051"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.10.5.780-786.2003"},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.6.1360"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.02.028"},{"key":"e_1_3_1_100_1","first-page":"1","volume":"54","author":"BILUKHA","year":"2005","unstructured":"BILUKHA OO, ROSENSTEIN N: Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. (2005) 54(RR-7):1-21.","journal-title":"MMWR Recomm Rep."},{"key":"e_1_3_1_101_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.159.10.907"},{"key":"e_1_3_1_102_1","doi-asserted-by":"publisher","DOI":"10.1086\/322567"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.1086\/322577"},{"key":"e_1_3_1_104_1","doi-asserted-by":"publisher","DOI":"10.1086\/322569"},{"key":"e_1_3_1_105_1","first-page":"1023","volume":"54","year":"2005","unstructured":"CENTERS FOR DISEASE CONTROL AND PREVENTION: Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine-United States, June-July 2005. MMWR Morb. Mortal. Wkly. Rep. (2005) 54(40):1023-1025.","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_1_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13779-8"},{"key":"e_1_3_1_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13811-1"},{"key":"e_1_3_1_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13917-7"},{"key":"e_1_3_1_109_1","doi-asserted-by":"publisher","DOI":"10.1086\/322571"},{"key":"e_1_3_1_110_2_1","unstructured":"http:\/\/www.clinicaltrials.gov\/ct\/gui\/show\/ NCT00134719 Study of Hib-MenCY-TT vaccine compared to licensed Hib and meningococcal serogroup C conjugate vaccines each administered at 2 4 6 and 12 to 15 months of age. GlaxoSmithKline (2005)."},{"key":"e_1_3_1_110_3_1","unstructured":"http:\/\/www.fda.gov\/cber\/vaccine\/licvacc.htm Vaccines licensed for immunization and distributed in the US. Food and Drug Administration and US Department of Health and Human Services (2005)."},{"key":"e_1_3_1_110_4_1","unstructured":"http:\/\/www.sanofipasteur.com\/sanofi-pasteur\/front\/templates\/vaccinations-travel-health-vaccine-aventis-pasteur.jsp?&lang=EN&codeRubrique=13&codePage=cpnewname FDA licenses Menactra\u2122 (meningococcal [Groups A C Y and W-135] olysaccharide diphtheria toxoid conjugate vaccine) for protection against meningococcal disease. SanofiPasteur (2005)."}],"container-title":["Expert Opinion on Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14740338.5.3.351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T19:34:29Z","timestamp":1770924869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14740338.5.3.351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,13]]},"references-count":110,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["10.1517\/14740338.5.3.351"],"URL":"https:\/\/doi.org\/10.1517\/14740338.5.3.351","relation":{},"ISSN":["1474-0338","1744-764X"],"issn-type":[{"value":"1474-0338","type":"print"},{"value":"1744-764X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,13]]}}}